Arkansas Health Center COVID-19 Survey Summary Report

Latest data from January 14, 2022

Number of Health Center respondents = 10 (83% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 25,493
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 36.75%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 6,905
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 43.60%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 61.06% 53.87%
White, Hispanic/Latino Patients 5.66% 7.24%
Black/African American, Non-Hispanic/Latino Patients 24.82% 27.62%
Black/African American, Hispanic/Latino Patients 0.16% 0.20%
Asian Patients3 0.66% 0.65%
American Indian/Alaska Native Patients3 0.18% 0.10%
Native Hawaiian/Other Pacific Islander Patients3 0.96% 1.43%
Patients with More Than One Race3 0.98% 1.17%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 2.06% 3.23%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.44% 0.51%
Unreported/Refused to Report Race and Ethnicity 3.02% 3.97%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 1,075
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 76.82%
COVID-19 Immunization Series Completed 545
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 65.64%
COVID-19 Immunization Series Additional 1,533
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 58.38%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 21.95% 32.66% 40.51%
White, Hispanic/Latino Patients 25.40% 20.00% 9.13%
Black/African American, Non-Hispanic/Latino Patients 27.81% 25.87% 41.55%
Black/African American, Hispanic/Latino Patients 0.09% 0.00% 0.13%
Asian Patients3 0.65% 0.55% 0.46%
American Indian/Alaska Native Patients3 0.19% 0.37% 0.59%
Native Hawaiian/Other Pacific Islander Patients3 2.70% 2.20% 0.20%
Patients with More Than One Race3 0.47% 0.92% 0.78%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 15.44% 12.48% 3.98%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.77% 2.20% 0.65%
Unreported/Refused to Report Race and Ethnicity 3.53% 2.75% 2.02%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 0.00%
1 to 24 Hours 10.00%
More Than 24 Hours 90.00%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 40.00%
Vaccine confidence 40.00%
Vaccine storage capacity 0.00%
Vaccine supply 10.00%
Other 10.00%
None 30.00%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 70.00%
Average Percent of Health Center Visits Conducted Virtually 15.50%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 50.00%
Number of Mobile Van Sites 5
Number of Pop-up Clinics 9
Number of School-Based Vaccination Sites 2
Number of Family Vaccination Clinics 3

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 70.00%
Refer patients to another organization that provides monoclonal antibody therapies 40.00%
None 10.00%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 0.00%
Patient awareness/education 0.00%
Staffing capacity 10.00%
Therapy administration/onsite logistics 10.00%
Other 0.00%
None 90.00%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 3
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 14,670

Test Kit Distribution Methods4

Metrics Value
Provide to Existing Health Center Patients 66.67%
Provide to General Public Who Came to the Health Center 100.00%
Provide at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 0.00%
Provide at Other Community Events 66.67%
Provide through direct outreach to specific populations (i.e., individuals experiencing homelessness, MSAWs, residents of public housing, individuals with limited English proficiency) 0.00%
Other 0.00%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 0
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 -

Oral Antiviral Medication Distribution by Race and Ethnicity5

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients -
White, Hispanic/Latino Patients -
Black/African American, Non-Hispanic/Latino Patients -
Black/African American, Hispanic/Latino Patients -
Asian Patients3 -
American Indian/Alaska Native Patients3 -
Native Hawaiian/Other Pacific Islander Patients3 -
Patients with More Than One Race3 -
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) -
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) -
Unreported/Refused to Report Race and Ethnicity -

Oral Antiviral Medication Distribution by Special/Vulnerable Population5

Metrics Value
Migratory/Agricultural Workers -
Patients Experiencing Homelessness -
Patients Who Are Residents of Public Housing -
Patients with Limited English Proficiency -
Children Under 18 Years of Age -

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed courses of COVID-19 oral antiviral medication received through the HRSA Health Center COVID-19 Therapeutics Program as the denominator.

Date Last Reviewed:  January 2022